Needham Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $12
Needham analyst Mike Cikos initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $12.
William Blair Initiates Coverage On Cellebrite DI with Outperform Rating
William Blair analyst Jonathan Ho initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Outperform rating.
Cowen & Co. Initiates Coverage On Cellebrite DI with Outperform Rating, Announces Price Target of $20
Cowen & Co. analyst Shaul Eyal initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Outperform rating and announces Price Target of $20.